|
C17ORF53 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.71540559534833E-12 |
| Normal-vs-Stage2 |
1.076370E-03 |
| Normal-vs-Stage3 |
4.38230000066042E-08 |
| Normal-vs-Stage4 |
1.106070E-02 |
| Stage1-vs-Stage2 |
3.464600E-01 |
| Stage1-vs-Stage3 |
1.394680E-04 |
| Stage1-vs-Stage4 |
1.968230E-01 |
| Stage2-vs-Stage3 |
8.774300E-02 |
| Stage2-vs-Stage4 |
4.073000E-01 |
| Stage3-vs-Stage4 |
6.756000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
4.15409995291327E-09 |
| Normal-vs-Asian |
8.332500E-02 |
| Caucasian-vs-AfricanAmerican |
7.974600E-01 |
| Caucasian-vs-Asian |
2.063400E-01 |
| AfricanAmerican-vs-Asian |
4.261200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
2.21433982261487E-12 |
| Male-vs-Female |
6.702000E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.61430000478191E-08 |
| Normal-vs-Extreme_Weight |
1.93070004428364E-10 |
| Normal-vs-Obese |
2.38330022384048E-10 |
| Normal-vs-Extreme_Obese |
5.904300E-03 |
| Normal_Weight-vs-Extreme_Weight |
2.336300E-02 |
| Normal_Weight-vs-Obese |
9.127000E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.976600E-03 |
| Extreme_Weight-vs-Obese |
1.033990E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.944400E-01 |
| Obese-vs-Extreme_Obese |
4.816500E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.648300E-04 |
| Normal-vs-Age(41-60Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(61-80Yrs) |
1.68076663698002E-12 |
| Normal-vs-Age(81-100Yrs) |
1.613870E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.821800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.250340E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.000500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.314000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.230000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.883200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
<1E-12 |
| Normal-VS-Type2 PRCC |
5.06290009916199E-10 |
| Normal-VS-KIRP CIMP |
1.836480E-04 |
| Normal-VS-Unclassified PRCC |
1.45110000016047E-07 |
| Type1 PRCC-VS-Type2 PRCC |
1.206020E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.85876999999612E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
4.766400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.400700E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
5.172600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.594300E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.59529997492791E-09 |
| Normal-vs-N1 |
2.03009999999448E-06 |
| Normal-vs-N2 |
5.884100E-02 |
| N0-vs-N1 |
2.418100E-03 |
| N0-vs-N2 |
1.085900E-02 |
| N1-vs-N2 |
9.979200E-01 |
|
|
